Partilhar
Informação da revista
Os mais lidos
2128
Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of CardiologyMiguel Nobre Menezes, Marta Tavares da Silva, Andreia Magalhães, Bruno Melica, Júlia Cristina Toste, Rita Calé, Manuel Almeida, Manuela Fiuza, Eduardo Infante de Oliveira
Rev Port Cardiol. 2024;43:35-48
2128
Acesso de texto completo
1595
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneRodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
Rev Port Cardiol. 2024;43:219-20
1595
Acesso de texto completo
1247
Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneJorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
Rev Port Cardiol. 2024;43:221-2
1247
Acesso de texto completo
1212
Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitusHugo Costa, Miguel Espírito-Santo, João Bispo, João Guedes, Jorge Mimoso, Hugo Palmeiro, Rui Baptista Gonçalves, Hugo Vinhas
Rev Port Cardiol. 2024;43:167-74
1212
Acesso de texto completo
1179
PrOgnosis in Pulmonary Embolism (PoPE): 30-Day mortality risk score based on five admission parametersFilipa Gerardo, Daniel Faria, Pedro Silvério António, João Baltazar Ferreira, Marco Beringuilho, Hilaryano Ferreira, Inês Fialho, Inês Miranda, ... João B. Augusto
Rev Port Cardiol. 2024;43:1-8
1179
Acesso de texto completo
1065
Assessment of subtle cardiac dysfunction induced by premature ventricular contraction using two-dimensional strain echocardiography and the effects of successful ablationZeki Doğan, Emine Çakcak Erden, İsmail Erden, Gökhan Bektaşoğlu
Rev Port Cardiol. 2024;43:25-32
1065
Acesso de texto completo
994
Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?Joana Delgado-Silva
Rev Port Cardiol. 2024;43:175-6
994
Acesso de texto completo
973
conTemporary reflectiOns regarding heart failure manaGEmenT – How to ovERcome the PorTuguese barriers (TOGETHER-PT)José Silva-Cardoso, Jonathan Santos, Inês Araújo, Aurora Andrade, Pedro Morais Sarmento, Paulo Santos, Brenda Moura, Irene Marques, ... Joana Pimenta
Rev Port Cardiol. 2024;43:225-35
973
Acesso de texto completo
932
Developments in sports cardiology: The way to a brighter futureJosé Miguel Viegas, Hélder Dores, António Freitas, Luna Cavigli, Flavio D’Ascenzi
Rev Port Cardiol. 2024;43:87-9
932
Acesso de texto completo
899
Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosisFrancisca Almeida, Alexandra Sousa
Rev Port Cardiol. 2024;43:203-12
899
Acesso de texto completo
894
The impact of echocardiographic indexation to evaluate cardiac reverse remodeling throughout pregnancy and postpartumAna Filipa Ferreira, Francisca Saraiva, Sílvia Oliveira Diaz, Maria João Azevedo, Carla Sousa, Adelino Leite-Moreira, Benedita Sampaio-Maia, Carla Ramalho, ... Inês Falcão-Pires
Rev Port Cardiol. 2024;43:107-27
894
Acesso de texto completo
893
Permanent pacemaker implantation after alcoholic septal ablation induced complete heart block: Long-term impactAndré Grazina, Isabel Cardoso, António Fiarresga, Sílvia Aguiar Rosa, Pedro Garcia Brás, Vera Ferreira, José Miguel Viegas, Bárbara Lacerda Teixeira, ... Rui Cruz Ferreira
Rev Port Cardiol. 2024;43:13-9
893
Acesso de texto completo
884
Home- versus centre-based EXercise InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trialCristine Schmidt, Sandra Magalhães, Priscilla Gois Basilio, Marisol Gouveia, Manuel Teixeira, Cláudio Santos, Aida Isabel Tavares, João Pedro Ferreira, ... Mário Santos
Rev Port Cardiol. 2024;43:149-58
884
Acesso de texto completo
804
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in PortugalKashish Zehra Manjee, Danish Hassan
Rev Port Cardiol. 2024;43:299-300
804
Acesso de texto completo
803
Perceptions of cardiology, professional preferences and impact on career choices among Portuguese cardiologists: Results from the Portuguese Society of Cardiology's Women and Cardiology Task Force surveyAna Teresa Timóteo, Regina Ribeiras, Cristina Gavina, Sofia Cabral, Ana G. Almeida, Natália António, Rita Calé, Brenda Moura, ... Lino Gonçalves
Rev Port Cardiol. 2024;43:189-99
803
Acesso de texto completo
802
Anomalous origin of the right coronary artery from the ascending aortaMesut Mutluoglu, Stefaan Gryspeerdt, Kristof De Smet
Rev Port Cardiol. 2024;43:51-2
802
Acesso de texto completo
796
A challenging dilemma: Can we predict which premature ventricular contractions may cause cardiomyopathy?Ana Galrinho
Rev Port Cardiol. 2024;43:33-4
796
Acesso de texto completo
788
Pericardial hemangioma – Imaging with pathologic correlation of an extremely rare mediastinal lesionFilipe Barros Alves, Margarida Ribeiro Morgado, André Carvalho, Mariana Vasconcelos, Pedro Rodrigues-Pereira, Sara Alves, Filipe Macedo, António José Madureira
Rev Port Cardiol. 2024;43:49-50
788
Acesso de texto completo
784
Underuse of reperfusion therapy with systemic thrombolysis in high-risk acute pulmonary embolism in a Portuguese centerMariana Martinho, Rita Calé, João Grade Santos, Ana Rita Pereira, Sofia Alegria, Filipa Ferreira, Maria José Loureiro, Tiago Judas, ... Hélder Pereira
Rev Port Cardiol. 2024;43:55-64
784
Acesso de texto completo
774
Characterization of cardiac arrhythmias and maternal–fetal outcomes in pregnant women: A prospective cohort studyEdison Muñoz-Ortiz, Andrés Felipe Miranda-Arboleda, Yesid Alberto Saavedra-González, Jairo Alfonso Gándara-Ricardo, Jesús Velásquez-Penagos, Natalia Giraldo-Ardila, Magnolia Zapata-Montoya, Erica Holguín-Gonzalez, ... Juan Manuel Senior-Sanchez
Rev Port Cardiol. 2024;43:67-74
774
Acesso de texto completo
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.